A. Riker

发表

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

S. Eschrich, A. Daud, O. Fodstad, 2008, BMC Medical Genomics.

A novel patient-derived xenograft model for claudin-low triple-negative breast cancer

E. Martin, L. Rhodes, S. Elliott, 2018, Breast Cancer Research and Treatment.

Emerging metabolic targets in cancer therapy.

Ming Tan, Hao Liu, O. Fodstad, 2011, Frontiers in bioscience.

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2019, bioRxiv.

Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor

H. Wathieu, S. Elliott, B. Collins-Burow, 2019, bioRxiv.

Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study

H. Gutman, A. Eggermont, J. Gershenwald, 2006, Annals of Surgical Oncology.

Advances in the early detection, diagnosis, and staging of pancreatic cancer.

S. Libutti, D. Bartlett, A. Riker, 1997, Surgical oncology.

Combination immunotherapy for high-risk resected and metastatic melanoma patients.

W. J. Ramsey, C. Link, A. Riker, 2014, The Ochsner journal.

Current immunotherapy of melanoma

V. Sondak, M. Fishman, A. Daud, 2005 .

Immunostimulatory Effects of CpG-ODN Upon Dendritic Cell-Based Immunotherapy in a Murine Melanoma Model

Jon J Briggs, J. Mulé, J. Djeu, 2004, Journal of immunotherapy.

CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus.

Y. Xi, Z. Qin, A. Riker, 2020, Biochemical and biophysical research communications.

In Regard to Vaidya et al.

A. Taghian, D. Wazer, P. Poortmans, 2015, International journal of radiation oncology, biology, physics.

ignificance of Sentinel Lymph Node icrometastases in Human Breast Cancer

H. E. Cox, J. Kiluk, A. Riker, 2008 .

Surgical management of patients with metastatic breast cancer

C. Cox, A. Riker, Suhu Liu, 2007 .

Palliative Resection of a Giant Mesenteric Desmoid Tumor.

A. Riker, J. Sugrue, Stephanie Cohen, 2015, The Ochsner journal.

Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy.

J. Taube, T. Olencki, E. Lipson, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer esearch oenvironment and Immunology plifying TLR-MyD 88 Signals within Tumor-Specific ells Enhances Antitumor Activity to Suboptimal R els of Weakly Immunogenic Tumor

S. Markovic, E. Davila, A. Riker, 2010 .

Successful removal of a giant intrathoracic lipoma: a case report and review of the literature

A. Riker, G. A. Nelson, Ramona M Hagmaier, 2008, Cases journal.

Recurrent angiomatoid fibrous histiocytoma: a case report and review of the literature.

A. Riker, R. Hammadeh, Quan Zhou, 2014, The Ochsner journal.

Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens.

E. Wang, U. Kammula, G. A. Ohnmacht, 1999, Journal of immunology.

Evidence of gender bias in patients undergoing flexible sigmoidoscopy.

E. Warner, H. Brownlee, P. Brady, 1997, Cancer detection and prevention.

Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis.

P. Fabri, J. Messina, A. Rosemurgy, 1995, Surgery.

Metastatic Papillary Thyroid Cancer to the Liver: The Central Role of a Multidisciplinary Approach to Treatment

A. Riker, B. Boulmay, I. Hodgdon, 2021, The Ochsner journal.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

J. Taube, T. Olencki, E. Lipson, 2021, Journal for ImmunoTherapy of Cancer.

Expression in Response to Vaccination Short-Term Kinetics of Tumor Antigen

S. Rosenberg, S. Mocellin, E. Wang, 2001 .

Comparative methodologies of regulatory T cell depletion in a murine melanoma model.

A. Riker, S. Pilon-Thomas, Norimasa Matsushita, 2008, Journal of immunological methods.

Current clinical trials for melanoma vaccines: where do we stand?

A. Riker, E. Bisgaard, 2016, Melanoma management.

Use of ipilimumab in melanoma.

A. Riker, D. Bourgeois, A. Rivere, 2011, Immunotherapy.

Highlights from the latest articles on the use of ipilimumab in melanoma Safety and efficacy profile of ipilimumab administration

A. Riker, D. Bourgeois, A. Rivere, 2022 .

The Hedgehog Pathway Transcription Factor GLI1 Promotes Malignant Behavior of Cancer Cells by Up-regulating Osteopontin*

R. Samant, A. Riker, Suhu Liu, 2009, The Journal of Biological Chemistry.

Immune selection after antigen-specific immunotherapy of melanoma.

S. Steinberg, F. Marincola, S. Rosenberg, 1999, Surgery.

Tyrosinase immunoreactivity in fine‐needle aspiration samples of metastatic malignant melanoma

F. Marincola, P. Fetsch, A. Abati, 2000, Cancer.

Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells

F. Marincola, Helen Y Wang, Rong-Fu Wang, 2002, The Journal of experimental medicine.

Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes

S. Steinberg, F. Marincola, S. Rosenberg, 2000, International journal of cancer.

Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells

J. Mulé, A. Riker, L. Kuhn, 2006, Cancer Immunology, Immunotherapy.

Expression of gp100 and CDK2 in melanoma cells is not co-regulated by a shared promoter region.

T. Miki, B. Nickoloff, A. Riker, 2004, Pigment cell research.

Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma.

E. Wang, P. Fetsch, A. Abati, 1999, Cancer detection and prevention.

Utility of fine-needle aspiration biopsy for prospective analysis of patients undergoing therapy for metastatic melanoma.

A. Riker, 2001, Methods in molecular medicine.

Melanoma antigen expression in serial fine‐needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials

S. Steinberg, F. Marincola, P. Fetsch, 2001, Cancer.

Elevated Osteopontin Levels in Metastatic Melanoma Correlate with Epigenetic Silencing of Breast Cancer Metastasis Suppressor 1

O. Fodstad, R. Samant, A. Riker, 2010, Oncology.

Radiotherapy for breast cancer, the TARGIT-A trial

M. Silverstein, D. Wazer, A. Riker, 2014, The Lancet.

Comment on Rahusen et al.

C. Cox, A. Riker, E. Dupont, 2004, The breast journal.

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Richard Heller, V. Sondak, P. Munster, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anesthetic Considerations for Intraoperative Radiation Therapy.

A. Riker, Kathryn M Glynn, 2015, The Ochsner journal.

Human Malignant Melanoma-Derived Progestagen-Associated Endometrial Protein Immunosuppresses T Lymphocytes In Vitro

Fumei Wang, A. Riker, Suping Ren, 2015, PloS one.

Neuropilin‐2 gene expression correlates with malignant progression in cutaneous melanoma

M. Mahalingam, R. Alani, B. Ryu, 2014, The British journal of dermatology.

The 14-3-3σ gene promoter is methylated in both human melanocytes and melanoma

O. Fodstad, A. Riker, Suhu Liu, 2009, BMC Cancer.

Immunotherapy as part of a multidisciplinary approach to melanoma treatment.

R. Jove, A. Daud, A. Riker, 2006, Frontiers in bioscience : a journal and virtual library.

Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.

A. Riker, Stephanie Cohen, Qing Fan, 2015, The Ochsner journal.

Interferon-γ Reduces Melanosomal Antigen Expression and Recognition of Melanoma Cells by Cytotoxic T Cells

Adam I. Riker, Francesco M. Marincola, Ena Wang, 2002 .

Mitf-Mdel, a novel melanocyte/melanoma-specific isoform of microphthalmia-associated transcription factor-M, as a candidate biomarker for melanoma

Yixiang Wang, H. Khong, A. Riker, 2010, BMC medicine.

Expansion of Tumor-T Cell Pairs from Fine Needle Aspirates of Melanoma Metastases

F. Marincola, S. Rosenberg, E. Wang, 2000, The Journal of Immunology.

Needle Aspirates of Melanoma Metastases Expansion of Tumor-T Cell Pairs from Fine Marincola

F. Marincola, S. Rosenberg, E. Wang, 1999 .

Immunotherapy of melanoma: a critical review of current concepts and future strategies

Yixiang Wang, H. Khong, A. Riker, 2007, Expert opinion on biological therapy.

Hereditary Breast Cancer Syndromes

C. Cox, A. Riker, J. Farma, 2011 .

Separation of 5′-dimethoxytrityl-2′-deoxynucleoside-3′-omethylphosphonamidite diastereomers by normal phase chromatography

E. Wickstrom, J. P. Rife, A. Lebedev, 1990 .

A Tumor-Infiltrating Lymphocyte from a Melanoma Metastasis with Decreased Expression of Melanoma Differentiation Antigens Recognizes MAGE-12

F. Marincola, S. Rosenberg, M. Panelli, 2000, The Journal of Immunology.

Epigenetic Biomarkers in Melanoma

A. Riker, Suhu Liu, Suping Ren, 2012 .

Epigenetics in human melanoma.

O. Fodstad, A. Riker, Suhu Liu, 2009, Cancer control : journal of the Moffitt Cancer Center.

Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol

Ming Zhou, Hao Liu, O. Fodstad, 2010, Molecular Cancer.

Cyclin G2, a novel target of sulindac to inhibit cell cycle progression in colorectal cancer

Hui-Yi Lin, Y. Xi, A. Riker, 2020, Genes & diseases.

Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer

E. Martin, S. Elliott, B. Collins-Burow, 2020, Women's health reports.

Metformin and cancer immunity

Y. Xi, Ruixia Ma, A. Riker, 2020, Acta Pharmacologica Sinica.

MicroRNAs are involved in the development and progression of gastric cancer

Y. Xi, Ruixia Ma, A. Riker, 2020, Acta Pharmacologica Sinica.

The Familial Atypical Multiple Mole Melanoma (FAMMM)-Pancreatic Carcinoma (PC) Syndrome

A. Riker, Ramona M Hagmaier, 2011 .

MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression*

Wei Xiong, Ming Tan, Zixing Liu, 2010, The Journal of Biological Chemistry.

MicroRNA in Melanoma.

Y. Xi, A. Riker, P. Howell, 2010, The Ochsner journal.

Overexpression of the progestagen-associated endometrial protein gene is associated with microphthalmia-associated transcription factor in human melanoma.

Wei Du, A. Riker, Suping Ren, 2011, The Ochsner journal.

Roscovitine Inhibits Differentiation and Invasion in a Three-Dimensional Skin Reconstruction Model of Metastatic Melanoma

Subhra Mohapatra, Domenico Coppola, D. Coppola, 2007, Molecular Cancer Research.

The impact of genomics in understanding human melanoma progression and metastasis.

Yaguang Xi, Jingfang Ju, Suhu Liu, 2008, Cancer control : journal of the Moffitt Cancer Center.

A personalized microRNA microarray normalization method using a logistic regression model

Bin Wang, Kun Huang, Xiao-Feng Wang, 2009, Bioinform..

Current concepts in biobanking: development and implementation of a tissue repository.

A. Riker, L. Shevde, 2009, Frontiers in bioscience.

Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti–PD-L1 Immunotherapy

Y. Xi, D. Wyczechowska, Li Li, 2021, Molecular Cancer Therapeutics.

Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor.

V. Sondak, A. Daud, D. Gabrilovich, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cutaneous melanoma: methods of biopsy and definitive surgical excision

V. Sondak, J. Messina, F. Glass, 2005, Dermatologic therapy.

Current Surgical Management of Primary Cutaneous Melanoma

J. Lam, A. Riker, S. Lambert, 2018 .

Current surgical management of melanoma

A. Riker, A. Morris, L. Thompson, 2006, Expert review of anticancer therapy.

Association of insulin-like growth factor binding protein-3 expression with melanoma progression

O. Fodstad, Y. Xi, J. Ju, 2006, Molecular Cancer Therapeutics.

Hospital-Based Same-Day Compared to Overnight-Stay Mastectomy: An American College of Surgeons National Surgical Quality Improvement Program Analysis

J. Klune, A. Riker, Justin J. Turcotte, 2022, Ochsner Journal.

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

H. Wathieu, E. Flemington, E. Martin, 2021, Clinical and Translational Oncology.

Cystatin E/M suppresses legumain activity and invasion of human melanoma

Jon J Briggs, G. Mælandsmo, M. Abrahamson, 2010, BMC Cancer.

Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ

E. Shelley Hwang, Ruixiao Lu, Julia White, 2016, Annals of Surgical Oncology.

A Case of Severe Anaphylactic Reaction Secondary to Isosulfan Blue Dye Injection.

Damaris Ortiz, A. Riker, Jurgis Alvikas, 2015, The Ochsner journal.

Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared to Non-Melanoma Skin Cancer

Pascal O. Zinn, Richard D. Kennedy, Adam I. Riker, 2011, The Journal of investigative dermatology.

Management of tracheobronchial strictures and fistulas: a report and review of literature.

W. Vigneswaran, A. Riker, 2002, International surgery.

Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.

O. Fodstad, Y. Xi, J. Ju, 2007, Cancer genomics & proteomics.

Up-Regulation of miR-182 Expression after Epigenetic Modulation of Human Melanoma Cells

A. Riker, Suhu Liu, P. Howell, 2013, Annals of surgical oncology.

Antigens Recognizes MAGE-12 Expression of Melanoma Differentiation Melanoma Metastasis with Decreased A Tumor-Infiltrating Lymphocyte from a Rosenberg and

F. Marincola, S. Rosenberg, M. Panelli, 2000 .

Development of Effective Therapeutics Targeting HER3 for Cancer Treatment

Bolin Liu, Xiaolong Liu, H. Lyu, 2019, Biological Procedures Online.

Current Management of Ductal Carcinoma In Situ (DCIS)

A. Riker, J. Walloch, B. Krueger, 2015 .

Sentinel node biopsy for thin melanomas: which patients should be considered?

V. Sondak, J. Messina, L. F. Glass, 2005, Cancer control : journal of the Moffitt Cancer Center.

Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma

L. Pannell, O. Fodstad, Y. Xi, 2009, Clinical & Experimental Metastasis.

Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination.

F. Marincola, P. Fetsch, A. Abati, 1998, Journal of immunology.

Carcinosarcoma of the breast: two case reports and review of the literature

A. Riker, J. Lazarchick, Ramona M Hagmaier, 2009, Cases journal.

Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells.

F. Marincola, E. Wang, June K. Robinson, 2002, The American journal of pathology.

Full-Thickness Grafts Procured from Skin Overlying the Sentinel Lymph Node Basin; Reconstruction of Primary Cutaneous Malignancy Excision Defects

V. Sondak, Daohai Yu, D. Reintgen, 2008, Annals of Surgical Oncology.

Isolation and culture of melanoma cell lines.

A. Riker, 2004, Methods in molecular medicine.

Functional characterization of the progestagen-associated endometrial protein gene in human melanoma

L. Pannell, O. Fodstad, R. Samant, 2009, Journal of cellular and molecular medicine.

Immunobiology of the Melanoma Microenvironment

Y. Kawakami, A. Riker, 2018 .

Activated stat-3 in melanoma.

Hua Yu, R. Jove, P. Munster, 2008, Cancer control : journal of the Moffitt Cancer Center.

Activated Stat3 in Melanoma

Hua Yu, R. Jove, P. Munster, 2008 .

The epidemiology, prevention, and detection of melanoma.

A. Riker, Nicolas Zea, T. Trinh, 2010, The Ochsner journal.

Vascular complications after femoral artery catheterization in burn patients.

R. Gamelli, A. Riker, 1996, The Journal of trauma.

Significance of sentinel lymph node micrometastases in human breast cancer.

D. Boulware, J. Kiluk, C. Cox, 2008, Journal of the American College of Surgeons.

Down-Regulation of Pro-Apoptotic Genes is an Early Event in the Progression of Malignant Melanoma

V. Sondak, J. Messina, A. Daud, 2007, Annals of Surgical Oncology.

CLINICAL CASE OF THE MONTH A 44-Year-Old Woman with Abdominal Pain Giant Pedunculated Cavernous Hepatic Hemangioma

B. Spieler, A. Riker, F. Lopez, 2018 .

A Case of Male Breast Cancer with a BRCA Gene Mutation.

A. Riker, M. Benjamin, 2015, Ochsner Journal.

Open Roux-en-Y gastric bypass for the morbidly obese in the era of laparoscopy.

R. Reddy, A. Riker, J. Brems, 2002, American journal of surgery.

Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination

F. Marincola, S. Rosenberg, S. Mocellin, 2001, The Journal of Immunology.

Aquaporins mediate the chemoresistance of human melanoma cells to arsenite

G. Piazza, R. Kumar, Y. Xi, 2012, Molecular oncology.

Abstract P5-17-03: The 12-gene DCIS score assay: Impact on radiation treatment (XRT) recommendations and clinical utility

H. Kuerer, Benjamin D. Smith, A. Recht, 2016 .

The Initial Consultation: Malignant Disease

A. Riker, B. Krueger, 2015 .

MICRORNA-125 B CONFERS THE RESISTANCE OF BREAST CANCER CELLS TO PACLITAXEL THROUGH SUPRESSION OF PRO-APOPTOTIC BCL-2 ANTAGONIST KILLER 1 ( BAK 1 ) EXPRESSION

W. Xiong, Gui-yuan Li, Ming Zhou, 2010 .

Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling

O. Fodstad, A. Riker, Suhu Liu, 2008, Pigment cell & melanoma research.

A phase II clinical trial of a novel combinatorial antitumor immunotherapy for patients with high-risk resected stage III and metastatic melanoma.

W. J. Ramsey, C. Link, A. Riker, 2010 .

Interferon- (cid:1) Reduces Melanosomal Antigen Expression and Recognition of Melanoma Cells by Cytotoxic T Cells

F. Marincola, E. Wang, B. Nickoloff, 2022 .

340 POSTER Gene therapy with plasmid IL-12 delivered by electroporation in patients with malignant melanoma: results of first human Phase I trial

V. Sondak, J. Messina, A. Daud, 2006 .

Gene expression A personalized microRNA microarray normalization method using a logistic regression model

Y. Xi, J. Ju, A. Riker, 2009 .

Improving Operating Room Efficiency: Relocating a Surgical Oncology Program Within a Health Care System

M. Bloomston, A. Riker, J. Higgins, 2022, Ochsner Journal.

Open Access Bmc Medical Genomics Exon Expression in Lymphoblastoid Cell Lines from Subjects with Schizophrenia before and after Glucose Deprivation

S. Eschrich, A. Daud, O. Fodstad, 2009 .

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

V. Sondak, P. Munster, D. Sullivan, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.